Endocrinology, Vol 131, 1689-1694, Copyright © 1992 by Endocrine Society

ARTICLES

A study of metabolism of deaminated and sulfoconjugated iodothyronines by rat placental iodothyronine 5-monodeiodinase

F Santini, RE Hurd and IJ Chopra
Department of Medicine, University of California School of Medicine, Los Angeles 90024.

The interaction of the rat placental type III iodothyronine 5- monodeiodinase (5-MD) with acetic acid (AA), propionic acid (PA), and sulfoconjugate (SA) derivatives of thyroid hormones has been investigated in comparison with hepatic iodothyronine type I MD. PA and AA derivatives of both T3 and T4 were potent inhibitors of 5- monodeiodination of [125I]T3 by rat placental microsomes. 3,5,3'- Triiodothyroacetic acid (T3AA) and 3,5,3'-triiodothyropropionic acid (T3PA) were comparable to T3 in their ability to inhibit 5- monodeiodination of [125I]T3, whereas T4AA and T4PA were more potent than T4. 3,5,3'-triiodothyrosulfonic acid (T3SA), T4SA, and rT3SA caused little or no inhibition of placental 5-MD activity. Among various analogs of T3 or T4, the order of relative potency of inhibition of hepatic 5'-MD was PA > AA > SA > parent iodothyronine. The metabolism of T3 and its derivatives by rat placental microsomes was studied by determining the rates of disappearance of the various substrates and the production of the metabolites generated by inner ring monodeiodination of the substrate. T3AA and T3PA were metabolized at a rate comparable to that of T3. Under the same conditions, essentially 100% of T3SA remained intact. Kinetic studies of placental inner ring monodeiodination of T3, T3AA, and T3PA demonstrated comparable values for Km (1.3, 1.8, and 2.3 nM, respectively) and maximum velocity (44, 57, and 74 fmol/micrograms.h, respectively). All derivatives of T3 studied were deiodinated by hepatic type I MD more avidly than the parent iodothyronine. Our data suggest that 1) deamination does not appreciably influence, while sulfoconjugation markedly inhibits type III 5-monodeiodination of T3; and 2) deamination may be even more conducive to degradation of thyroid hormone than sulfoconjugation.

This article has been cited by other articles:

				J. Kohrle, F. Jakob, B. Contempre, and J. E. Dumont Selenium, the Thyroid, and the Endocrine System Endocr. Rev., December 1, 2005; 26(7): 944 - 984. [Abstract] [Full Text] [PDF]

				M. H. A. Kester, E. Kaptein, T. J. Roest, C. H. van Dijk, D. Tibboel, W. Meinl, H. Glatt, M. W. H. Coughtrie, and T. J. Visser Characterization of Human Iodothyronine Sulfotransferases J. Clin. Endocrinol. Metab., April 1, 1999; 84(4): 1357 - 1364. [Abstract] [Full Text]

				F. Santini, L. Chiovato, P. Ghirri, P. Lapi, C. Mammoli, L. Montanelli, G. Scartabelli, G. Ceccarini, L. Coccoli, I. J. Chopra, et al. Serum Iodothyronines in the Human Fetus and the Newborn: Evidence for an Important Role of Placenta in Fetal Thyroid Hormone Homeostasis J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 493 - 498. [Abstract] [Full Text]

				E. C. H. Friesema, R. Docter, E. P. Krenning, M. E. Everts, G. Hennemann, and T. J. Visser Rapid Sulfation of 3,3',5'-Triiodothyronine in Native Xenopus laevis Oocytes Endocrinology, February 1, 1998; 139(2): 596 - 600. [Abstract] [Full Text] [PDF]

				E. Kaptein, G. A. C. van Haasteren, E. Linkels, W. J. de Greef, and T. J. Visser Characterization of Iodothyronine Sulfotransferase Activity in Rat Liver Endocrinology, December 1, 1997; 138(12): 5136 - 5143. [Abstract] [Full Text] [PDF]

				G. N. Burrow, D. A. Fisher, and P. R. Larsen Maternal and Fetal Thyroid Function N. Engl. J. Med., October 20, 1994; 331(16): 1072 - 1078. [Full Text]